BR0017366A - Detecção de agentes infecciosos usando imitadores de antìgeno - Google Patents

Detecção de agentes infecciosos usando imitadores de antìgeno

Info

Publication number
BR0017366A
BR0017366A BR0017366-5A BR0017366A BR0017366A BR 0017366 A BR0017366 A BR 0017366A BR 0017366 A BR0017366 A BR 0017366A BR 0017366 A BR0017366 A BR 0017366A
Authority
BR
Brazil
Prior art keywords
antigen
detection
infectious agents
antibody
binding
Prior art date
Application number
BR0017366-5A
Other languages
English (en)
Inventor
Franco Felici
Nicola Gargano
Olga Minenkova
Paolo Monaci
Original Assignee
Kent S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kent S R L filed Critical Kent S R L
Publication of BR0017366A publication Critical patent/BR0017366A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"DETECçãO DE AGENTES INFECCIOSOS USANDO IMITADORES DE ANTìGENO". A presente invenção refere-se a um método para realizar o diagnóstico de um antígeno, compreendendo identificar a especificidade de ligação das moléculas de anticorpo de antiantígeno no soro através de metodologia de Detecção de Anticorpo através de Imitador de Antígeno (ADAM), compreendendo avaliar bibliotecas de fago usando soros de pacientes infectados com antígeno e indivíduos não-infectados, identificação dé peptídeos que ligam anticorpos (ligantes) especificamente associados ao dito antígeno. Aperfeiçoamentos no método são realizados através de estratégias de maturação in vitro; ligação de ligantes a um núcleo comum, tal como MAP. Em particular o método se aplica a HCV.
BR0017366-5A 2000-11-03 2000-11-03 Detecção de agentes infecciosos usando imitadores de antìgeno BR0017366A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2000/000442 WO2002037115A1 (en) 2000-11-03 2000-11-03 Detection of infectious agents using antigen mimics

Publications (1)

Publication Number Publication Date
BR0017366A true BR0017366A (pt) 2004-06-15

Family

ID=11133576

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0017366-5A BR0017366A (pt) 2000-11-03 2000-11-03 Detecção de agentes infecciosos usando imitadores de antìgeno

Country Status (12)

Country Link
EP (1) EP1332369A1 (pt)
JP (1) JP2004513346A (pt)
KR (1) KR20030084895A (pt)
CN (1) CN1455866A (pt)
AU (1) AU2001218836A1 (pt)
BR (1) BR0017366A (pt)
CA (1) CA2427602A1 (pt)
HU (1) HUP0302103A3 (pt)
MX (1) MXPA03003794A (pt)
PL (1) PL364832A1 (pt)
SK (1) SK5362003A3 (pt)
WO (1) WO2002037115A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2108656A1 (en) 2008-03-19 2009-10-14 Beninati, Concetta Antigenic protein fragments of streptococcus pneumoniae
WO2009158682A2 (en) * 2008-06-27 2009-12-30 Watkinson D Tobin Compositions and methods for diagnosing and treating pathogenic disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2172305A1 (en) * 1995-03-30 1996-10-01 Muneo Aoyama Multiple antigenic peptide comprising at least two hepatitis c virus-associated peptides
AU3714499A (en) * 1998-05-14 1999-11-29 Pasteur Merieux Serums Et Vaccins Hepatitis c virus mimotopes

Also Published As

Publication number Publication date
KR20030084895A (ko) 2003-11-01
CN1455866A (zh) 2003-11-12
EP1332369A1 (en) 2003-08-06
MXPA03003794A (es) 2004-10-15
CA2427602A1 (en) 2002-05-10
JP2004513346A (ja) 2004-04-30
HUP0302103A2 (hu) 2003-09-29
HUP0302103A3 (en) 2007-03-28
WO2002037115A1 (en) 2002-05-10
AU2001218836A1 (en) 2002-05-15
PL364832A1 (en) 2004-12-27
SK5362003A3 (en) 2003-09-11

Similar Documents

Publication Publication Date Title
Chia et al. Serological differentiation between COVID-19 and SARS infections
He et al. Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus
BRPI0111731C1 (pt) suporte sólido de imunoensaio, métodos de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e de produção de um suporte sólido de imunoensaio, e, kit de teste de imunodiagnóstico
TR200000113T2 (tr) Tüberkülozu teşhis etmek için bileşikler ve bunları kullanma yöntemleri.
Höhlich et al. Identification of foot-and-mouth disease virus-specific linear B-cell epitopes to differentiate between infected and vaccinated cattle
TW200512457A (en) Method of diagnosing SARS corona virus infection
Lee et al. Increased detection of hepatitis C virus infection in commercial plasma donors by a third‐generation screening assay
CN108333344A (zh) 高灵敏度的化学发光免疫分析试剂盒及其制备方法和应用
Emmerich et al. Longitudinal detection of SARS‐CoV‐2‐specific antibody responses with different serological methods
Pang et al. Bioscreening specific peptide-expressing phage and its application in sensitive dual-mode immunoassay of SARS-CoV-2 spike antigen
BR0200986A (pt) Ensaio de combinação anticorpo - antìgeno da hepatite c para a detecção precoce da infecção
ATE445839T1 (de) Latentes tuberkulose-diagnostisches antigen und verwendungsmethode
BR0017366A (pt) Detecção de agentes infecciosos usando imitadores de antìgeno
DE602005009819D1 (de) Verfahren zum nachweis von infektionen mit mykobakterien
Deshpande et al. Unveiling the quest: crafting an enzyme-linked immunosorbent assay (ELISA) technique to uncover COVID-19 antibodies
DK0755517T3 (da) Fremgangsmåde til detektion af tilstedeværelse af en Mycobacterium-art og et kit og antistoffer til anvendelse i denne
Bes et al. Hepatitis C virus (HCV)‐specific T‐cell responses among recombinant immunoblot assay‐3–indeterminate blood donors: a confirmatory evidence of HCV exposure
US20040152070A1 (en) Method of detection of HCV antibodies in combination assay or sole antibody assay
Montebugnoli et al. A rapid test for the visual detection of anti-hepatitis C virus antibodies in whole blood
Salminen et al. Anti-HCV immunoassays based on a multiepitope antigen and fluorescent lanthanide chelate reporters
Karamitros et al. Detection of specific antibodies to HCV‐ARF/CORE+ 1 protein in patients treated with pegylated interferon plus ribavirin
El Awady et al. Synthetic peptide-based immunoassay as a supplemental test for HCV infection
La Montagne et al. Severe acute respiratory syndrome: developing a research response
Shichijo et al. Assessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long‐lasting immunity
Attallah et al. A novel antigen detection immunoassay for field diagnosis of hepatitis C virus infection

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1942 25 - 03 - 2008.